At Novartis, we are an innovative medicines company driven by our purpose: to reimagine medicine and improve and extend people's lives. Every day, we strive to empower individuals, healthcare professionals, and societies in the face of serious diseases.
By leveraging technological leadership in R&D and novel access approaches, we deliver high-value medicines designed to alleviate society’s greatest disease burdens. Our goal is clear—to transform the healthcare landscape through early interventions, pioneering treatments, and innovative partnerships. We specifically target cardiovascular disease (CVD)—the world’s biggest killer—and rare and progressive kidney diseases, aiming to prevent avoidable mortality and ease the burden on individuals by extending dialysis-free life.
In this new era, our commitment remains unwavering. Together, let’s reimagine medicine to improve and extend people’s lives.
15 October 2025
18:00
CET
Europe/ParisUnlocking insights from cardiology data with NLPAccess event page https://esc365.escardio.org/event/20002025-10-15T18:00:002025-10-15T19:00:00
Register to Access
Unlocking insights from cardiology data with NLP
31 October 2025
18:00
CET
Europe/ParisLipoprotein(a): current role and future perspectives in cardiovascular medicineAccess event page https://esc365.escardio.org/event/21592025-10-31T18:00:002025-10-31T19:00:00
Register to Access
Lipoprotein(a): current role and future perspectives in cardiovascular medicine